Trial intelligence / Profile preview

Tranexamic acid and postoperative cognitive function in elderly non-cardiac surgery

ChiCTR2200056462Phase 4Recruiting

Sponsor
The Fourth Hospital of Harbin Medical University
Start
Nov 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in Postoperative neurocognitive disorder (PND), postoperative delirium (POD) and post-operative cognitive decline (POCD) comparing Tranexamic acid arm with Placebo saline arm (2 arms). Primary endpoint: Postoperative delirium. Started Nov 2021; status: recruiting.

02

Drugs

tranexamic acid
03

Conditions

Postoperative neurocognitive disorder (PND)postoperative delirium (POD)post-operative cognitive decline (POCD)

Beyond the preview

Go deeper on ChiCTR2200056462.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200056462.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call